SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Of White River Capital, Inc. (RVR), BioMimetic Therapeutics Inc. (BMTI) , Jeffries Group, Inc. (JEF) And Provectus Pharmaceuticals, Inc. (PVCT)
NEW YORK, Nov. 21, 2012 /PRNewswire/ --
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )
White River Capital, Inc.Levi & Korsinsky is investigating the Board of Directors of White River Capital, Inc. (NYSE MKT: RVR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company and its subsidiary, Coastal Credit, LLC, to an affiliate of Parthenon Capital Partners for $23 per share.
Click here to learn more about the investigation http://zlk.9nl.com/white-river-capital-rvr .
BioMimetic Therapeutics Inc.Levi & Korsinsky is investigating the Board of Directors of BioMimetic Therapeutics Inc. (NasdaqGS: BMTI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Wright Medical Group Inc. (NasdaqGS: WMGI) under which shareholders BioMimetic shareholders will receive $1.50 in cash and 0.2482 shares of Wright common stock for each share of BioMimetic stock they own. Click here to learn more about the investigation http://zlk.9nl.com/biomimetic-bmti . Jeffries Group, Inc.Levi & Korsinsky is investigating the Board of Directors of Jeffries Group, Inc. (NYSE: JEF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to its largest shareholder, Leucadia National Corp. (NYSE: LUK) under which shareholders will receive 0.81 Leucadia shares for each share of Jefferies stock they own, representing an approximate value of $17.24 per share. At least one analyst set a price target of $19.00 per Jefferies share. Click here to learn more about the investigation http://zlk.9nl.com/jefferies-group-jef , or call: 877-363-5972. Provectus Pharmaceuticals, Inc.Levi & Korsinsky, LLP is investigating Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), and its Board of Directors in connection with the compensation provided to certain of its executive officers. To get more information, click here: http://zlk.9nl.com/provectus-pharmaceuticals-pvct , or call: 877-363-5972 Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq.30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com SOURCE Levi & Korsinsky, LLP
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
